RealClearHealth - Opinion, News, Analysis, Video and Polls

The FDA’s recent closed-door roundtable with more than a dozen rare-disease advocacy groups hinted at a real reset after a stretch... Read More

Precision genetic medicine has advanced to the point where therapies can be designed to target a single pathogenic mutation in a handful of... Read More

We’re happy to report that Fox News covered the latest Unleash Prosperity Now study on how speeding up drug approvals by opening... Read More

Forty years of studies find higher cancer risks among children exposed during pregnancy and early life to pesticides used on farms, lawns,... Read More

Vermont’s new paraquat ban’s political signal could travel much farther than its practical effect. The weedkiller’s acute toxicity is... Read More

The Covid lockdowns may not have been effective, but at least they harmed people and created negative impacts that we’re still dealing with. Read More

Remember when pro-lockdown public health experts said protesting was OK if it was against racism? Read More

In his most urgent TED Talk yet, Jon Haidt reminds us that human connection is not optional. Read More

This ALS Awareness Month, lawmakers and regulators face a pivotal moment in the fight against ALS. For the first time in history - following... Read More

The programs operate as open-ended entitlements, making it hard to separate outright scams from aggressive but routine billing. Read More

The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More

Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More

I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More

If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More

The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More

On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More

This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More

Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More